Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for DRUG stands at 49.901, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 1.122, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 59.883 and the Commodity Channel Index (CCI) at 17.495 further confirm a 4.91 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, DRUG is trading above its 60-day moving average of $83.218 and above its 200-day long-term moving average of $55.096. Key price levels to watch include the immediate resistance at $92.123 and strong support at $77.453. A break above $92.123 could signal a bull continuation, while falling below $77.453 may test the next Fibonacci floor at $69.556.

Bright Minds Biosciences Inc (DRUG) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	62.783	69.556	77.453	84.226	92.123	98.896	106.792
Fibonacci	69.556	75.16	78.622	84.226	89.83	93.292	98.896

Bright Minds Biosciences Inc (DRUG) Technical Indicators

2026-03-02

Name	Value
RSI_14	49.901
STOCHk_14_3_3	59.883
STOCHd_14_3_3	72.716
CCI_20	17.495
AO_5_34	3.008
MOM_10	4.91
MACD_12_26_9	1.122

Bright Minds Biosciences Inc (DRUG) Relative Strength Index (RSI) is 49.901, creating a Neutral signal.

Bright Minds Biosciences Inc (DRUG) Stochastic Oscillator is 59.883, creating a Neutral signal.

Bright Minds Biosciences Inc (DRUG) Stochastic RSI is 72.716, creating a Neutral signal.

Bright Minds Biosciences Inc (DRUG) Commodity Channel Index (CCI) is 17.495, creating a Neutral signal.

Bright Minds Biosciences Inc (DRUG) Awesome Oscillator is 3.008, creating a Buy signal.

Bright Minds Biosciences Inc (DRUG) Momentum is 4.91, creating a Buy signal.

Bright Minds Biosciences Inc (DRUG) MACD is 1.122, creating a Buy signal.

Bright Minds Biosciences Inc (DRUG) Moving Average

2026-03-02

Period	Simple	Signal
MA_5	86.244	Sell
MA_10	85.349	Sell
MA_20	80.976	Buy
MA_60	83.218	Sell
MA_200	55.096	Buy
MA_250	50.712	Buy

Bright Minds Biosciences Inc (DRUG) 5-Day simple moving average is 86.244, while Bright Minds Biosciences Inc (DRUG) share price is $82.81, making it a Sell.

Bright Minds Biosciences Inc (DRUG) 10-Day simple moving average is 85.349, while Bright Minds Biosciences Inc (DRUG) share price is $82.81, making it a Sell.

Bright Minds Biosciences Inc (DRUG) 20-Day simple moving average is 80.976, while Bright Minds Biosciences Inc (DRUG) share price is $82.81, making it a Buy.

Bright Minds Biosciences Inc (DRUG) 60-Day simple moving average is 83.218, while Bright Minds Biosciences Inc (DRUG) share price is $82.81, making it a Sell.

Bright Minds Biosciences Inc (DRUG) 200-Day simple moving average is 55.096, while Bright Minds Biosciences Inc (DRUG) share price is $82.81, making it a Buy.

Bright Minds Biosciences Inc (DRUG) 250-Day simple moving average is 50.712, while Bright Minds Biosciences Inc (DRUG) share price is $82.81, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for DRUG?

The overall technical consensus for Bright Minds Biosciences Inc (DRUG) is currently Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 1 sell signals.

What are the key support and resistance levels for Bright Minds Biosciences Inc (DRUG) today?

Based on pivot point calculations, Bright Minds Biosciences Inc (DRUG) has an immediate support level at 77.453 and a major resistance level at 92.123. Traders also monitor the pivot point at 84.226 to determine the intraday trend direction.

Is Bright Minds Biosciences Inc (DRUG) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Bright Minds Biosciences Inc (DRUG) is currently 49.901. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Bright Minds Biosciences Inc (DRUG)?

Bright Minds Biosciences Inc (DRUG) Moving Averages Convergence Divergence (MACD) indicator is 1.122, suggesting DRUG is Buy. This indicator helps identify potential trend reversals or momentum shifts for Bright Minds Biosciences Inc.

How is Bright Minds Biosciences Inc (DRUG) performing relative to its 200-day moving average?

Bright Minds Biosciences Inc (DRUG) is currently trading at $82.81, which is above its 200-day simple moving average of 55.096. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.

DRUG Technical

DRUG Technical

Technical Sentiment

Overall Consensus

Technical Analysis Consensus

Moving Average Consensus

Technical Analysis for DRUG